Successful treatment of a panniculitis-like primary cutaneous T-cell lymphoma of the α/β type with bexarotene

Case Reports in Dermatology

Volumn 4, Issue 1, 2012, Pages 56-60

  Zhang, X ^a   Schlaak, M ^a   Fabri, M ^a   Mauch, C ^a   Kurschat, P ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Bexarotene; Cutaneous T cell lymphoma; Lymphoma; Panniculitis; Retinoids; Therapy

Indexed keywords

BEXAROTENE; CD3 ANTIGEN; CD8 ANTIGEN; IBUPROFEN; PERFORIN; PREDNISONE; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; BONE MARROW BIOPSY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; FEVER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MONOTHERAPY; NIGHT SWEAT; NUCLEAR MAGNETIC RESONANCE IMAGING; PANNICULITIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN BIOPSY; STAINING; SUBCUTANEOUS NODULE; SUBCUTANEOUS T CELL LYMPHOMA; T LYMPHOCYTE; TREATMENT RESPONSE;

EID: 84860727198     PISSN: None     EISSN: 16626567     Source Type: Journal    
DOI: 10.1159/000337433     Document Type: Article

References (11)

1. Willemze R, Jansen PM, Cerroni L, Berti E, Santucci M, Assaf C, Canninga-van Dijk MR, Carlotti A, Geerts ML, Hahtola S, Hummel M, Jeskanen L, Kempf W, Massone C, Ortiz-Romero PL, Paulli M, Petrella T, Ranki A, Peralto JL, Robson A, Senff NJ, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ: Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood 2008;111:838-845.
2. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ: WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768-3785.
3. Jaffe ES: The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program 2009:523-531.
4. Gonzalez CL, Medeiros LJ, Braziel RM, Jaffe ES: T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol 1991;15:17-27.
5. Boehm MF, Zhang L, Badea BA, White SK, Mais DE, Berger E, Suto CM, Goldman ME, Heyman RA: Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids. J Med Chem 1994;37:2930-2941.
6. Duvic M, Hymes K, Heald P, Breneman D, Martin AG, Myskowski P, Crowley C, Yocum RC: Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results. J Clin Oncol 2001;19:2456-2471.
7. Hashimoto H, Sawada K, Koizumi K, Nishio M, Endo T, Takashima T, Kobayashi H, Koike T: Effective CD34+ selected autologous peripheral blood stem cell transplantation in a patient with subcutaneous panniculitic T cell lymphoma (SPTCL) transformed into leukemia. Bone Marrow Transplant 1999;24:1369-1371.
8. Haycox CL, Back AL, Raugi GJ, Piepkorn M: Subcutaneous T-cell lymphoma treated with systemic chemotherapy, autologous stem cell support, and limb amputation. J Am Acad Dermatol 1997;37:832-835.
9. Briki H, Bouaziz JD, Molinier-Frenkel V, Delfau-Larue MH, Ortonne N, Bagot M: Subcutaneous panniculitis-like T-cell lymphoma aß: complete sustained remission with corticosteroids and methotrexate. Br J Dermatol 2010;163:1136-1138.
10. Hathaway T, Subtil A, Kuo P, Foss F: Efficacy of denileukin diftitox in subcutaneous panniculitis -like T-cell lymphoma. Clin Lymphoma Myeloma 2007;7:541-545.
11. Miller VA, Benedetti FM, Rigas JR, Verret AL, Pfister DG, Straus D, Kris MG, Crisp M, Heyman R, Loewen GR, Truglia JA, Warrell RP Jr: Initial clinical trial of a selective retinoid X receptor ligand, LGD1069. J Clin Oncol 1997;15:790-795.